Can a keto diet boost breast cancer treatment?

NCT ID NCT03962647

First seen May 06, 2026 ยท Last updated May 06, 2026

Summary

This study tested whether a 2-week very low-carb (ketogenic) diet combined with the hormone therapy letrozole is feasible and tolerable for postmenopausal women with early-stage estrogen receptor-positive (ER+) breast cancer. 31 participants followed the diet before surgery. The goal was to see if the diet could help the drug work better by affecting insulin and cancer growth signals. The study focused on whether people could stick to the diet and if it changed markers like Ki67 in tumors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESTROGEN RECEPTOR POSITIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.